Major non-ABO incompatibility caused by anti-Jka in a patient before allogeneic hematopoietic stem cell transplantation

Immunohematology

Volumn 29, Issue 1, 2013, Pages 11-14

  Kim, Miriam Y ^a   Chaudhary, Preeti ^a   Shulman, Ira A ^b   Pullarkat, Vinod ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

Anti Jka; Hematopoietic stem cell transplantation; Major incompatibility

Indexed keywords

BILIRUBIN; BLOOD GROUP ANTIGEN; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD; BLOOD GROUP INCOMPATIBILITY; CASE REPORT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED;

ANTIGEN-ANTIBODY REACTIONS; BILIRUBIN; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED;

EID: 84885768703     PISSN: 0894203X     EISSN: 19303955     Source Type: Journal    
DOI: 10.21307/IMMUNOHEMATOLOGY-2019-117     Document Type: Article

References (14)

1. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000;96:1150-6.
2. Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 2011;46:1167-85.
3. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999;39:763-71.
4. Ramsey G, Larson P. Loss of red cell alloantibodies over time. Transfusion 1988;28:162-5.
5. Leo A, Mytilineos J, Voso MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jka after allogeneic PBPC transplantation. Transfusion 2000;40:632-6.
6. Young PP, Goodnough LT, Westervelt P, Diersio JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:1305-10.
7. Adams BR, Miller AN, Costa LJ. Self-limited hemolysis due to anti-D passenger lymphocyte syndrome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2009;45:772-3.
8. López A, de la Rubia J, Arriaga F, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998;38:247-51.
9. Perseghin P, Balduzzi A, Galimberti S, et al. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:231-6.
10. Borge PD, Stroka-Lee AH, Hsieh MM, et al. Delayed red blood cell chimerism in an HSC transplant for sickle cell disease associated with a non-ABO alloantibody (abstract). Transfusion 2010;50(Suppl 2):155A.
11. Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361:2309-17.
12. Fenchel K, Bergmann L, Wijermans P, et al. Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas. Leuk Lymphoma 1995;18:485-92.
13. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101:3857-61.
14. Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.